Patents Assigned to Foundation
  • Patent number: 7754351
    Abstract: The present invention provides free-standing heterostructures including a layer of BiFeO3 and a layer comprising a perovskite over which the BiFeO3 is epitaxially grown. The layer comprising the perovskite has been released from a substrate upon which it was originally grown. Also provided are methods for forming the free-standing heterostructures, which may include transferring the free-standing heterostructures to other host substrates.
    Type: Grant
    Filed: May 8, 2008
    Date of Patent: July 13, 2010
    Assignee: Wisconsin Alumni Research Foundation (WARF)
    Inventors: Chang-Beom Eom, Ho Won Jang
  • Patent number: 7754211
    Abstract: Novel immunotoxins and methods of treating neoplastic diseases are provided. More specifically, immunotoxins comprised conjugation of a c-erbB-2 targeting moiety and a cell growth modulator are provided. These immunotoxins specifically and selectively kill tumor cells that over-express the c-erbB-2 protein. The novel immunotoxins would be useful in treating human mammary carcinomas, human ovarian carcinomas, lung carcinomas, gastric tumors, salivary gland adenocarcinomas, and colon adenocarcinomas.
    Type: Grant
    Filed: October 13, 2004
    Date of Patent: July 13, 2010
    Assignee: Research Development Foundation
    Inventors: Michael Rosenblum, Laura K. Shawver
  • Patent number: 7754144
    Abstract: An austenitic stainless steel HTUPS alloy includes, in weight percent: 15 to 30 Ni; 10 to 15 Cr; 2 to 5 Al; 0.6 to 5 total of at least one of Nb and Ta; no more than 0.3 of combined Ti+V; up to 3 Mo; up to 3 Co; up to 1 W; up to 0.5 Cu; up to 4 Mn; up to 1 Si; 0.05 to 0.15 C; up to 0.15 B; up to 0.05 P; up to 1 total of at least one of Y, La, Ce, Hf, and Zr; less than 0.05 N; and base Fe, wherein the weight percent Fe is greater than the weight percent Ni wherein said alloy forms an external continuous scale comprising alumina, nanometer scale sized particles distributed throughout the microstructure, said particles comprising at least one composition selected from the group consisting of NbC and TaC, and a stable essentially single phase fcc austenitic matrix microstructure, said austenitic matrix being essentially delta-ferrite-free and essentially BCC-phase-free.
    Type: Grant
    Filed: April 16, 2008
    Date of Patent: July 13, 2010
    Assignees: UT-Battelle, LLC, University of Tennessee Research Foundation
    Inventors: Michael P Brady, Michael L Santella, Yukinori Yamamoto, Chain-tsuan Liu
  • Patent number: 7756563
    Abstract: A method provides guidance to the physician during a live bronchoscopy or other endoscopic procedures. The 3D motion of the bronchoscope is estimated using a fast coarse tracking step followed by a fine registration step. The tracking is based on finding a set of corresponding feature points across a plurality of consecutive bronchoscopic video frames, then estimating for the new pose of the bronchoscope. In the preferred embodiment the pose estimation is based on linearization of the rotation matrix. By giving a set of corresponding points across the current bronchoscopic video image, and the CT-based virtual image as an input, the same method can also be used for manual registration. The fine registration step is preferably a gradient-based Gauss-Newton method that maximizes the correlation between the bronchoscopic video image and the CT-based virtual image. The continuous guidance is provided by estimating the 3D motion of the bronchoscope in a loop.
    Type: Grant
    Filed: May 19, 2006
    Date of Patent: July 13, 2010
    Assignee: The Penn State Research Foundation
    Inventors: William E. Higgins, Scott A. Merritt, Lav Rai
  • Patent number: 7754874
    Abstract: The present invention provides methods of producing libraries of compounds with enhanced desirable properties and diminished side effects as well as the compounds produced by the methods. In preferred embodiments, methods of the present invention use a universal chemical glycosylation method that employs reducing sugars and requires no protection or activation. In a preferred embodiment, the invention provides a library of neoglycoside digitoxin analogs that includes compounds with significantly enhanced cytotoxic potency toward human cancer cells and tumor-specificity, but are less potent Na+/K+-ATPase inhibitors in a human cell line than digitoxin.
    Type: Grant
    Filed: June 24, 2005
    Date of Patent: July 13, 2010
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Jon S. Thorson, Joseph M. Langenhan
  • Publication number: 20100170674
    Abstract: A process and apparatus of separating CO2 gas from industrial off-gas source is provided in which the CO2 containing off-gas is introduced deep within an injection well. The CO2 gases are dissolved in the liquid within the injection well while non-CO2 gases, typically being insoluble in water or brine, are returned to the surface. Once the CO2 saturated liquid is present within the injection well, the injection well may be used for long-term geologic storage of CO2 or the CO2 saturated liquid can be returned to the surface for capturing a purified CO2 gas.
    Type: Application
    Filed: January 7, 2010
    Publication date: July 8, 2010
    Applicants: Savannah River Nuclear Solutions, LLC, Clemson University Research Foundation
    Inventors: Gerald Blount, Alvin A. Siddal, Ronald W. Falta
  • Publication number: 20100171531
    Abstract: An output buffer including a first differential input stage, a primary output stage, and a secondary output stage is provided herein. The first differential input stage respectively receives a first and a second input signals via a first and a second input terminals. The primary output stage includes a first and a second output stages. The first output stage provides at least one first level voltage according to the first and the second input signals, and the second output stage controlled by the first level voltage drives an output terminal of the output buffer to a target level. The secondary output stage includes a comparator and a third output stage. The comparator compares the induced currents in the first differential input stage, and thereby generates a control voltage. The third output stage controlled by the control voltage drives the output terminal of the output buffer to the target level.
    Type: Application
    Filed: January 8, 2009
    Publication date: July 8, 2010
    Applicants: HIMAX TECHNOLOGIES LIMITED, NCKU Research & Development Foundation
    Inventors: Chien-Hung Tsai, Jia-Hui Wang, Jing-Chuan Qiu, Chen-Yu Wang
  • Publication number: 20100173186
    Abstract: Disclosed are an organic electrolyte for a lithium-ion battery and a lithium-ion battery comprising the same, wherein the electrolyte includes a base electrolyte containing a lithium salt dissolved in an organic solvent, and diphenyloctyl phosphate added thereto in an amount of 0.1 to 20 wt %. As compared to a conventional organic electrolyte using only a carbonate ester-based solvent, such as ethylene carbonate, ethyl methyl carbonate, etc., the lithium-ion battery employing the organic electrolyte can improve thermal stability of an electrolyte solution, high-rate performance, and charge/discharge cyclability of a battery, while maintaining battery performance of the base electrolyte.
    Type: Application
    Filed: June 10, 2008
    Publication date: July 8, 2010
    Applicant: Sungkyunkwan University Foundation for Corporate Collaboration
    Inventors: Jung Gu Kim, Eun Gi Shim, Tae Heum Nam
  • Publication number: 20100172840
    Abstract: A lanthanoid metal catalyst for the formation carbon nanotubes from a carbon-containing gas mixture, a method for the formation of carbon nanotubes with the lanthanoid metal catalyst, endohedral carbon nanotube complexes containing lanthanoid metal atoms and/or ions, carbon nanotube imaging contrast agents, and a method for imaging living tissue with carbon nanotube imaging contrast agents are provided.
    Type: Application
    Filed: September 29, 2009
    Publication date: July 8, 2010
    Applicant: The Research Foundation of State University of New York
    Inventors: Balaji SITHARAMAN, Magdalena Swierczewska
  • Publication number: 20100173937
    Abstract: Provided are methods of modulating, treating, reversing and/or preventing pain using tetrakis quaternary ammonium compounds, especially regarding pain of central and/or peripheral origin and/or pain which is nociceptive, neuropathic, somatic, visceral, and/or inflammatory in nature.
    Type: Application
    Filed: December 7, 2009
    Publication date: July 8, 2010
    Applicants: University of Kentucky Research Foundation, University of Utah
    Inventors: Joseph R. HOLTMAN, Peter A. Crooks, Linda P. Dwoskin, J. Michael McIntosh
  • Publication number: 20100173589
    Abstract: A method and apparatus of improving capacity of channel is disclosed. A vector X(t) is generated based on a cycle period 1/T of a wide-sense cyclo-stationary (WSCS) noise and a whitening filter W(t) for decorrelating the WSCS noise in frequency domain. A scalar signal X(t) is generated by shifting the vector X(t) in the frequency domain.
    Type: Application
    Filed: October 26, 2009
    Publication date: July 8, 2010
    Applicant: POSTECH Academy-Industry Foundation
    Inventors: Byung Wook Han, Joon Ho Cho
  • Publication number: 20100172952
    Abstract: A porous scaffold is disclosed, the porous scaffold comprising electrospun polymeric nanofibers, wherein an average diameter of a pore of the porous scaffold is about 300 ?m is disclosed. An average diameter of the polymeric nanofibers ranges from about 100 to 400 nm. The scaffold may comprise a plurality of particles, the particles being greater than about 1 ?m in diameter. Methods of fabricating scaffolds, methods for generating tissue and methods of using scaffolds for tissue reconstruction are also disclosed.
    Type: Application
    Filed: January 31, 2008
    Publication date: July 8, 2010
    Applicant: Technion Research & Development Foundation Ltd.
    Inventors: Samer Srouji, Eyal Zussman, Erella Livne
  • Publication number: 20100172587
    Abstract: A method for setting a lip region of a face included in an image, including setting a first region and a second region in an image including a face, identifying contrast information of the first region, setting a threshold for binarization using the contrast information, and binarizing the second region based on the threshold. A region in which a pixel having an identical binary value continuously distributed within a predetermined number of ranges in the binarized image is set as an eye candidate object. An eye region is then extracted from the eye candidate object based on geometric characteristic of an eye region in an image, and the lip region is set with reference to the extracted eye region based on geometric information of the eye region and the lip region.
    Type: Application
    Filed: December 23, 2009
    Publication date: July 8, 2010
    Applicants: Samsung Electronics Co., Ltd., Industry Foundation of Chonnam National University
    Inventors: Seong-Taek HWANG, Yin-Young Kim
  • Publication number: 20100173796
    Abstract: The present invention relates to a screening method of an amphiphilic peptide specifically binding to hairpin RNA, more precisely a screening method of an amphiphilic peptide having specificity and strong binding strength to target hairpin RNA using peptide library comprising those peptides having modifications of both hydrophilic face and hydrophobic face. The method of the present invention provides a screening method of an amphiphilic peptide which is specific to hairpin RNA. So, the peptide selected by the method of the present invention can be effectively used for the study of hairpin RNA functions and for the production of a novel drug using an artificial peptide binding to a hairpin RNA target.
    Type: Application
    Filed: August 12, 2009
    Publication date: July 8, 2010
    Applicant: SNU R&DB Foundation
    Inventors: Jaehoon YU, Jeffrey Kieft, Su Jin Lee
  • Publication number: 20100174859
    Abstract: A set of data is stored in an input space of a kernel content addressable memory. The input space comprising the set of data is transformed into a feature space of higher dimension. The set of data is a set of transformed data within the feature space. An inner product is calculated between the set of transformed data in the feature space using a kernel function.
    Type: Application
    Filed: January 6, 2010
    Publication date: July 8, 2010
    Applicant: University of Florida Research Foundation, Inc.
    Inventors: JOSE C. PRINCIPE, Erion Hasanbelliu, Weifeng Liu
  • Publication number: 20100170563
    Abstract: Embodiments of the invention pertain to the use of alloyed semiconductor nanocrystals for use in solar cells. The use of alloyed semiconductor nanocrystals offers materials that have a flexible stoichiometry. The alloyed semiconductor may be a ternary semiconductor alloy, such as AxB1-xC or AB1-yCy, or a quaternary semiconductor alloy, such as AxByC1-x-yD, AxB1-xCyD1-y or ABxCyD1-x-y (where A, B, C, and D are different elements). In general, alloys with more than four elements can be used as well, although it can be much harder to control the synthesis and quality of such materials. Embodiments of the invention pertain to solar cells having a layer incorporating two or more organic materials such that percolated paths for one or both molecular species are created. Specific embodiments of the invention pertain to a method for fabricating nanostructured bulk heterojunction that facilitates both efficient exciton diffusion and charge transport.
    Type: Application
    Filed: May 23, 2008
    Publication date: July 8, 2010
    Applicant: University of Florida Research Foundation, Inc.
    Inventor: Jiangeng Xue
  • Publication number: 20100173841
    Abstract: A novel type A botulinum toxin preparation is provided. A neuromuscular transmission blocking agent comprising as an active ingredient a highly purified type A botulinum toxin from Clostridium botulinum as infant botulism pathogen and a medicament for treating a disease with a muscle overactivity comprising as an active ingredient said toxin. In particular, the medicament of the present invention, as compared to the conventional known botulinum toxin preparations, has rapid efficacy of potential and is less diffusive and thus, having a broader safety margin, may be used as therapeutic medicament for decreasing local, muscle overactivity in a disease with a muscle overactivity.
    Type: Application
    Filed: October 26, 2007
    Publication date: July 8, 2010
    Applicant: Juridical Foundation the Chemo-Sero-Therapeutic Research Institute
    Inventors: Tetsuhiro Harakawa, Hirotoshi Nakano, Yasushi Torii, Yoshitaka Goto, Miho Shinmura, Sachio Okuda, Ryuji Kaji, Shunji Kosaki
  • Publication number: 20100173402
    Abstract: The present invention relates to novel methods and compositions for detection and isolation of cancer cells with metastatic potential. The invention further relates to assays for measuring the metastatic potential of such cancer cells and drug screening assays for the identification of agents having anti-metastatic potential. The present invention further provides methods and compositions for inhibiting the metastatic potential of cancer cells by modulating the activity of serine integral membrane proteases [(SIMP) consisting of seprase and dipetidyl peptidase IV (DPPIV)] expressed on the surface of metastasizing cancer cells.
    Type: Application
    Filed: March 16, 2010
    Publication date: July 8, 2010
    Applicant: The Research Foundation of State University of New York
    Inventor: Wen-Tien Chen
  • Patent number: 7749725
    Abstract: The present invention relates to a method for screening drugs for use in treating hypertension using the tubular renin-angiotensinogen system identified by the present invention. The invention further relates to a method to diagnose sodium status and sensitivity in an individual by measuring urinary angiotensinogen or angiotensin-I.
    Type: Grant
    Filed: October 16, 2002
    Date of Patent: July 6, 2010
    Assignee: University of Utah Research Foundation
    Inventors: Andreas Rohrwasser, Terry Morgan, Jean-Marc Lalouel
  • Patent number: 7749765
    Abstract: The present invention provides compositions and methods for extracting, isolating, and measuring lead dissolved in aqueous solutions, including water.
    Type: Grant
    Filed: August 3, 2006
    Date of Patent: July 6, 2010
    Assignee: University of Virginia Patent Foundation
    Inventors: James N. Demas, Wenying Xu